STAT3 and Hepatitis: The findings in our study indicated that MSCs- or TSG6-induced suppression of hepatic STAT3 activation might play a beneficial role in relieving liver injury, liver inflammation, and hepatic steatosis and in modulating the inflammatory responses (Figs. 3, 4, and 5).